Breadth of anti-phospholipid mAb inhibition of HIV-1 infectivity against R5 and R5/X4 replicating HIV-1 Renilla reporter viruses engineered to express five transmitted/founder env genes, B.BaL env, and B.SF162LS env in the PBMC infectivity assay
| HIV-1 genes in NL-LucR.T2A-ENV.ecto virusesa | mAbsb | Coreceptor usage | |||||
| IS4 | CL1 | P1 | PGN632 | Anti-RSV | 4E10 | ||
| µg/ml | µg/ml | µg/ml | µg/ml | µg/ml | µg/ml | ||
| B.BaL | 0.58 | 2.2 | 0.11 | <0.02 | >50 | 1.6 | CCR5 |
| B.WITO | 0.06 | <0.02 | <0.02 | <0.02 | >50 | 0.16 | CCR5 |
| B.CH040 | <0.02 | <0.02 | <0.02 | <0.02 | >50 | <0.02 | CCR5 |
| B.CH058 | 0.37 | 0.17 | 0.29 | <0.02 | >50 | 3.6 | CCR5 |
| B.CH077 | 16 | 46 | 5.5 | 0.07 | >50 | 3.0 | CCR5 |
| B.SF162LS | 1.5 | 2.6 | 0.4 | <0.02 | >50 | 2.5 | CCR5 |
| B.WEAU410 | >50 | >50 | >50 | >50 | >50 | 4.5 | CXCR4/CCR5 |
| HIV-1 genes in NL-LucR.T2A-ENV.ecto virusesa | mAbsb | Coreceptor usage | |||||
| IS4 | CL1 | P1 | PGN632 | Anti-RSV | 4E10 | ||
| µg/ml | µg/ml | µg/ml | µg/ml | µg/ml | µg/ml | ||
| B.BaL | 0.58 | 2.2 | 0.11 | <0.02 | >50 | 1.6 | CCR5 |
| B.WITO | 0.06 | <0.02 | <0.02 | <0.02 | >50 | 0.16 | CCR5 |
| B.CH040 | <0.02 | <0.02 | <0.02 | <0.02 | >50 | <0.02 | CCR5 |
| B.CH058 | 0.37 | 0.17 | 0.29 | <0.02 | >50 | 3.6 | CCR5 |
| B.CH077 | 16 | 46 | 5.5 | 0.07 | >50 | 3.0 | CCR5 |
| B.SF162LS | 1.5 | 2.6 | 0.4 | <0.02 | >50 | 2.5 | CCR5 |
| B.WEAU410 | >50 | >50 | >50 | >50 | >50 | 4.5 | CXCR4/CCR5 |